HIVE Digital Technologies stock (CVE: HIVE) has seen some massive growth recently. In the second quarter, the company posted a whopping 285% jump year-on-year in its revenue to a record $87.3 million.
The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to ...
Some of the best growth stocks started out as penny stocks, and digging for small-cap companies can lead to significant gains ...
Detailed price information for Hive Blockchain Technologies Inc (HIVE-X) from The Globe and Mail including charting and trades.
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated November 25, 2025 to its short form base shelf prospectus dated October 31, 2025 ...
Explore the best US-accessible, fully managed Bitcoin cloud mining platforms in 2025, offering zero-hardware contracts, transparent terms, and regulatory peace of mind.
If these bees could be trained, multiplied and cared for, the risk of honey collection would vanish. And the income would ...
The average one-year price target for HIVE Digital Technologies (NasdaqCM:HIVE) has been revised to $6.46 / share. This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback